Cerebrolysin
A brain-derived peptide mixture studied in neurological disease; clinical research does not mean established benefit.
Human evidenceRead evidence profile
Explore the science. Separate human findings from preclinical signals, and see what the evidence leaves unanswered.
Human evidence: selected controlled clinical research or its systematic review, not an endorsement. Primarily preclinical: mostly animal or laboratory findings. Mixed / limited human: different study types, with small or narrowly focused human studies. These labels describe the cited evidence, not regulatory status or a ranking of compounds.
8 profiles
Try a broader term or reset your search and filters.
A brain-derived peptide mixture studied in neurological disease; clinical research does not mean established benefit.
Human evidenceRead evidence profileA GLP-1 analogue with randomized human evidence; trial outcomes remain specific to the studied population and formulation.
Human evidenceRead evidence profileA dual GIP/GLP-1 receptor agonist studied in controlled metabolic trials, distinct from single-receptor compounds.
Human evidenceRead evidence profileA triple-receptor agonist with published phase 2 human research; this entry describes that study, not current approval status.
Human evidenceRead evidence profileA gastric-peptide research topic with predominantly animal evidence and major gaps in reliable human safety data.
Primarily preclinicalRead evidence profileA growth hormone-releasing factor analogue with human research in HIV-associated abdominal fat accumulation.
Human evidenceRead evidence profileA copper-binding tripeptide studied in cell, animal, and cosmetic contexts; those evidence types are not interchangeable.
Mixed / limited humanRead evidence profileA mitochondrial-derived peptide investigated in metabolic signalling; the foundational intervention findings are from mice.
Primarily preclinicalRead evidence profile